This report provides an integrated analysis of relationships between antimicrobial consumption in humans and food- producing animals and the occurrence of antimicrobial resistance in bacteria from humans and food- producing animals, respectively.
Genetic and antigenic characterization data generated at the Worldwide Influenza Centre for viruses with collection dates after 31 January 2023 until 31 August 2023 informed the WHO influenza vaccine composition meeting (VCM) in September 2023 when recommendations were made for the southern hemisphere (SH) 2024 influenza season.
HelicsWin.Net (also referred to as HWN) is a software application developed for the manual entry of data of the ECDC HAI-Net surveillance of healthcare-associated infections (HAIs).
This issue of the ECDC Communicable Disease Threats Report (CDTR) the period 11-17 February 2024, and includes updates on SARS-CoV-2 variant classification, diphtheria, chikungunya, dengue, influenza A(H5N1), a human case of co-infection with seasonal influenza A(H3N2) and avian influenza A(H10N5), Middle East respiratory syndrome coronavirus (MERS-CoV), and an overview of respiratory virus epidemiology in the EU/EEA.
Since the beginning of 2023, and as of 16 February 2024, six MERS-CoV cases, including two fatalities, have been reported with the date of onset in 2023 by Saudi Arabia (5) and the United Arab Emirates (1).
Since the beginning of 2023, and as of 16 February 2024, six MERS-CoV cases, including two fatalities, have been reported with the date of onset in 2023 by Saudi Arabia (5) and the United Arab Emirates (1).
Since the beginning of 2023, and as of 16 February 2024, six MERS-CoV cases, including two fatalities, have been reported with the date of onset in 2023 by Saudi Arabia (5) and the United Arab Emirates (1).
This course focuses on antimicrobial stewardship as an approach to address healthcare-associated infections (HAI) resulting from multi-drug resistance organisms in acute care settings.
Since the most recent ECDC rapid risk assessment in 2021, the number of EU/EEA countries reporting hypervirulent Klebsiella pneumoniae (hvKp) sequence type (ST) 23 has increased from four to ten and the number of cases reported to ECDC by the countries, increased from 12 to 143.